Filing Details
- Accession Number:
- 0001072613-12-000039
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-01-31 16:16:01
- Reporting Period:
- 2012-01-27
- Filing Date:
- 2012-01-31
- Accepted Time:
- 2012-01-31 16:16:01
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1526119 | Verastem Inc. | VSTM | Pharmaceutical Preparations (2834) | 273269467 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1384619 | Chp Iii Lp | C/O Cardinal Partners 230 Nassau Street Princeton NJ 08542 | No | No | Yes | No | |
1540704 | Chp Iii Management, L.l.c. | C/O Cardinal Partners 230 Nassau Street Princeton NJ 08542 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2012-01-27 | 1,984,126 | $0.00 | 1,984,126 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2012-01-27 | 250,000 | $10.00 | 2,234,126 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series A Preferred Stock | Disposition | 2012-01-27 | 4,000,000 | $0.00 | 1,142,857 | $0.00 |
Common Stock | Series B Preferred Stock | Disposition | 2012-01-27 | 2,500,000 | $0.00 | 714,285 | $0.00 |
Common Stock | Seriec C Preferred Stock | Disposition | 2012-01-27 | 444,444 | $0.00 | 126,984 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of preferred stock converted into approximately 0.29 shares of common stock upon the closing of the issuer's initial public offering. The shares have no expiration date.
- CHP III Management, L.L.C.(the "GP") is the sole General Partner of CHP III, L.P. John K. Clarke, Brandon H. Hull, Charles G. Hadley and John J. Park (collectively, the "Managing Members") are Managing Members of the GP, and, as such, may be deemed to have shared voting and dispositive power with respect to the issuer's securities held of CHP III, L.P. (the "CHP III Shares"). Each of the GP and the Managing Members disclaims beneficial ownership of the CHP III Shares, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the shares for purposes of Section 16 or for any other purpose.